Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Delayed

Explore clinical trials studying Hypersensitivity, Delayed. Study availability and eligibility vary by location and protocol.

13 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Hypersensitivity, Delayed trial results

Completed

The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge

NCT04454229

Conditions
Hypersensitivity, Hypersensitivity Response, Hypersensitivity, Delayed, +2 more
Locations
  • Duke University Medical Center Durham, North Carolina, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • Austin Health Heidelberg, Victoria, Australia
  • Peter MacCallum Cancer Center Melbourne, Victoria, Australia
View Trial Details
Completed

A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen

NCT00000782

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +16 more
Locations
  • Stanford CRS Palo Alto, California, United States
  • Santa Clara Valley Med. Ctr. San Jose, California, United States
  • San Mateo County AIDS Program San Mateo, California, United States
  • NY Univ. HIV/AIDS CRS New York, United States
View Trial Details
Completed

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

NCT00000891

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • Univ of Colorado Health Sciences Ctr Denver, Colorado, United States
  • Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States
  • Case Western Reserve Univ Cleveland, Ohio, United States
View Trial Details
Completed

A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis

NCT02195349

Conditions
Hypersensitivity, Hypersensitivity, Delayed, Immune System Diseases, +4 more
Locations
  • GSK Investigational Site Bonn, North Rhine-Westphalia, Germany
  • GSK Investigational Site Berlin, Germany
  • GSK Investigational Site London, United Kingdom
View Trial Details

Related conditions